Total Prostate Volume as Risk Factor for Semen Pathologies in Aging Male

October 2010 in “ Journal of Men's Health ”

AusmeesK., ZarkovskiM., TimbergG., KorrovitsP., PunabM.

5α-reductase inhibitors androgenetic alopecia benign prostatic hypertrophy interleukin-6 PSA levels 5-alpha-reductase inhibitors male pattern baldness BPH IL-6 prostate-specific antigen

TLDR Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The study investigated the relationship between semen quality, lower urinary tract symptoms (LUTS), and prostate volume in aging men. A total of 316 men aged 45-67 were examined, with semen samples assessed according to WHO guidelines. The study found that sperm concentration and motility negatively correlated with total prostate volume and LUTS, while testicular size positively correlated with sperm concentration and motility. Additionally, seminal plasma interleukin-6 levels positively correlated with total prostate volume and PSA levels. The results suggest that semen pathologies and reduced fertility rates may be associated with LUTS and prostate diseases in aging men. However, future research is needed to directly define these relationships and examine the treatment effects of LUTS on fertility rates. The document also discusses the potential persistent adverse effects of 5α-reductase inhibitors, used to treat androgenetic alopecia and benign prostatic hypertrophy, on sexual function, depression, and quality of life, suggesting that physicians should exercise caution and thoroughly discuss these issues with patients before prescribing this therapy.

View this study on liebertpub.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 180 results

community Evolution theory: AGA is your body trying to reduce the risk of prostate cancer by exposing your scalp to more UV

in Research/Science 3 months ago

Androgenic alopecia (AGA) might have evolved to reduce prostate cancer risk by increasing UV exposure to the scalp, but this theory is debated. Treatments like minoxidil and finasteride are used for AGA, though the exact causes and evolutionary reasons for hair loss are unclear.

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 1 year ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 41 upvotes 6 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community Massive study on finasteride side effects released

in Finasteride/Dutasteride 83 upvotes 3 years ago

The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

community Testosterone and Estradiol levels on 1 mg/day dutasteride

in Finasteride/Dutasteride 42 upvotes 5 months ago

A 30-year-old man experienced significant hair regrowth and improved libido after using finasteride and dutasteride for androgenetic alopecia, with no adverse effects. He plans to reduce dutasteride dosage when trying to conceive and has been using topical minoxidil since 2015.

community Fresh off the press: Dutasteride may cause chronic infertility

in Research/Science 643 upvotes 11 months ago

Dutasteride may cause chronic infertility by reducing semen volume and motility, with concerns about irreversible prostate fibrosis. Users consider switching to finasteride or using treatments like minoxidil and microneedling, weighing hair preservation against fertility.

Similar Research

6 / 1000+ results

research Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage: An Experimental Animal Study

10 citations , May 2019 in “International Journal of Environmental Research and Public Health”

Finasteride may cause kidney damage.

research Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

November 2023 in “Frontiers in Neuroendocrinology”

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

research Functional Complexity of Hair Follicle Stem Cell Niche and Therapeutic Targeting of Niche Dysfunction for Hair Regeneration

59 citations , March 2020 in “Journal of Biomedical Science”

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

research Consequences of Steroid-5α-Reductase Deficiency and Inhibition in Vertebrates

21 citations , January 2020 in “General and Comparative Endocrinology”

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

research Men's Health

February 1999 in “Drugs in R & D”

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

research Redefining Hormone Resistance in Prostate Cancer

38 citations , December 2009 in “Therapeutic Advances in Medical Oncology”

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.